GeneMatch is a research program of the Alzheimer’s Prevention Registry to identify a large group of people interested in participating in Alzheimer’s research studies based on their genetic information. The information you provide will remain secure and confidential. It will be used to help potentially connect you to research studies. Whether you pursue participation in a study is entirely up to...
Study Type: Observational Studies, Online Studies and Surveys, Prevention Studies
The Generation Program is made up of two clinical trials: Generation Study 1 and Generation Study 2.
These studies will test medications that may prevent Alzheimer’s.
We’re looking for volunteers who have 1 or 2 copies of the APOE e4 gene. These genetic profiles may increase a person’s risk of developing Alzheimer’s.
Participants should have normal memory & thinking ability (no diagnosis...
Location: Multiple Sites
Study Type: Prevention Studies
Age: 60 to 75
up to 12 visits in first year, 4 visits a year thereafter
Following safety screening and week 1 of following their usual schedules, participants will be randomly assigned (by chance) to one of two groups. One group will nap every day for 1 hour for three weeks (weeks 2-4), and the other group will read or rest quietly for 1 hour per day for weeks 2-4. After week 1 and after week 4, several measures will be taken, including mood, memory, blood levels...
This longitudinal research program is designed to characterize the biological and cognitive changes that precede the onset of memory and thinking problems in people at different levels of genetic risk for Alzheimer’s disease.
MindCrowd is a first-of-its-kind web-based memory study to identify cognitive performance outliers and to better understand their genetic differences. In Phase I, the goal is to have 1 million individuals, aged 18+, take the 10-minute online test and gather information for a more detailed Phase II study.
Study Type: Observational Studies, Online Studies and Surveys
THE PARKINSON’S PROGRESSION MARKERS INITIATIVE (PPMI) is a landmark study launched in 2010 to find biomarkers - disease indicators that are critical missing links in the search for better Parkinson’s disease (PD) treatments.
Recent research suggests there may be a link between sleep, cognitive dysfunction, and Alzheimer’s disease. This research study is testing whether an investigational medication (Piromelatine), which has sleep promoting effects, can help to slow cognitive deterioration, or improve cognitive function.
Location: Multiple Sites
Study Type: Studies for People w/ Memory Impairment
The Rush Memory Clinic Data and Repository is presented to individuals over 18 years old interested in participating in research studies conducted by or in association with the RADC. You will be asked to participate in an interview that may be conveniently conducted over the phone or at your home, and donate the information collected to the Repository. If you agree, participation in this study...